Integra LifeSciences Holdings Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (23)

View All

Latest Posts

About This Stock More About This Stock
Wall Street Stalls As Default Deadline Looms
Article By: Schaeffers Research
Tuesday, May 23, 2023 12:20 PM EDT
Wall Street is lower this afternoon as the default debate rages on.
In this article: PLT, QQQ, IART, SPX, VIX, DJI, ARKK, CWBR
Read
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Article By: Benzinga
Sunday, February 14, 2021 5:56 PM EDT
Biotech stocks advanced in the week ended Feb. 12, thanks to market strength and company-specific catalysts. Small and mid-cap earnings, multiple conference presentations, data readouts, and a slew of IPOs were all part of the week's news flow.
In this article: EBS, SNY, REGN, EXAS, MEDP, OCGN, WST, IART, GMED, SWAV
Read
Bull Of The Day: Penumbra (PEN)
Article By: Kevin Cook
Tuesday, September 25, 2018 2:30 PM EDT
Penumbra made a strong swing to sustainable profitability this year on the back of projected 27.5% sales growth from last year's $333 million to over $425 million in revenue.
In this article: PEN Also: ABT, BAX, EW, JNJ, MDT, SYK, IART, AXGN, MZOR
Read
Biotech Digest – KTOV Buys Stake, JNJ Reports Positive Results, NVS Receives CE Mark
Article By: KKD Healthcare Analytics
Monday, October 9, 2017 8:52 AM EDT
Kitov Pharmaceuticals announced that it has acquired an additional 27% stake in privately held TyrNovo, a developer of small molecule oncology drugs.
In this article: KTOV, JNJ, NVS, ABEO, FLXN, IART, BABY, TRPX, CTLT
Read
Morning Call For Monday, Dec. 12
Article By: Jim Van Meerten
Monday, December 12, 2016 8:25 AM EDT
Mar E-mini S&Ps (ESH17 +0.01%) are little changed, down -0.02%, as they fell back from a contract high in overnight trade. European stocks are up +0.08% at a 11-1/4 month high.
In this article: BCO, COP, HBI, CSOD, SGEN, IART
Read
All Posts

Latest Tweets for $IART

No tweets yet!

PARTNER HEADLINES